Patent ID: 11918591
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 5:
6. The pharmaceutical composition according to claim 3 for treatment of infections caused by enveloped pathogens and their variants, in particular coronaviridae (SARS-CoV, MERS-CoV, SARS-CoV-2), Herpesviridae (Herpes simplex, Varicella zoster, EBV, HHV-6 to 7, Monkey Herpes B), retroviruses (lentiviruses including HIV-1 and HIV-2, oncoviruses, and spumaviruses), myxoviruses, paramyxoviridae (para-influenza, mumps, measles, Respiratory Syncytial Virus), rabies virus, Lassa virus, hantavirus, Marburg virus, rubella virus and in the treatment of cancers.